Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-08

FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved a supplemental application for Diazepam from Natco Pharma USA LLC (ANDA 211998). This action confirms the continued approval/availability of the ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)